Engineering of macrophages to produce IFN-γ in response to hypoxia

Journal of Immunology

Volumn 166, Issue 9, 2001, Pages 5374-5380

  Carta, L ^a   Pastorino, S ^a   Melillo, G ^a   Bosco, M C ^a   Massazza, S ^a   Varesio, L ^a  

^a G GASLINI INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

FC RECEPTOR; GAMMA INTERFERON; IA ANTIGEN;

ANIMAL CELL; ARTICLE; CELL LINE; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE RELEASE; GENETIC TRANSFECTION; HYPOXIA; INTERFERON PRODUCTION; MACROPHAGE; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0035339931     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.166.9.5374     Document Type: Article

References (37)

1. Regulation of macrophage chemokine expression by lipopolysaccharide in vitro and in vivo
2. Regulation of macrophage gene expression by pro- and anti-inflammatory cytokines
3. Regulation of nitric oxide synthase expression in IFNγ-treated murine macrophages cultured under hypoxic conditions
4. Macrophage responses to hypoxia: Relevance to desease mechanisms
5. Hypoxia, clonal selection, and the role of HIF-1 in tumor progression
6. Oxygen sensing, hypoxia-inducible factor-1 and the regulation of mammalian gene expression
7. 2 tension
8. Hypoxia-inducible factor 1 and the molecular physiology of oxygen homeostasis
9. Regulation of nitric oxide synthase mRNA expression by interferon γ and picolinic acid
10. A hypoxia-responsive element mediates a novel pathway of activation of the inducible nitric oxide synthase promoter
11. Functional requirement of the hypoxia-responsive element in the activation of the inducible nitric oxide synthase promoter by the iron chelator desferrioxamine
12. Desferrioxamine induces erythropoietin gene expression and hypoxia-inducible factor 1 DNA-binding activity: Implications for models of hypoxia signal transduction
13. Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth
14. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumors
15. Adoptive immunotherapy of cancer using monocyte-derived macrophages: Rationale, current status, and perspective
16. Induction of antitumor immunity with dendritic cells transduced with adenovirus vector-encoding endogenous tumor-associated antigens
17. Induction of potent antitumor response by vaccination with tumor lysate-pulsed macrophages engineered to secrete macrophages colony-stimulating factor and interferon-γ
18. Increased in vitro and in vivo tumoricidal activity of a macrophage cell line genetically engineered to express IFN3γ, IL4, IL6, or TNFα
19. Pharmacokinetics, single-dose tolerance, and biological activity of recombinant γ-interferon in cancer patients
20. Adoptive immunotherapy with tumor-cytotoxic macrophages: Phase I trial to study the mobilization of blood myocytes with recombinant human granulocyte-macrophage colony-stimulating factor
21. A murine macrophage cell line, immortalized by v-raf and v-myc oncogene exhibited normal macrophage differentiated functions
22. hckl
23. TNF-α-dependent production of reactive nitrogen intermediates regulates IFN-γ plus IL-2 induced murine macrophage tumoricidal activity
24. Role of interferon-γ in immune cell regulation
25. Requirement for transcription factor IRF-1 in NO synthase induction in macrophages
26. How cells respond to interferons
27. Picolinic acid, a catabolite of L-tryptophan, is a co-stimulus for the induction of reactive nitrogen intermediate production in murine macrophages
28. Ribosomal RNA metabolism in macrophages
29. Physiology mechanisms of posthischemic tissue injury
30. Immunoprevention of cancer: Is the time ripe?
31. Gene transfer of IFN-γ into established brain tumors represses growth by antiangiogenesis
32. Angiogenesis and angiogenesis inhibition: An overview
33. The macrophage-a novel system to deliver gene therapy to pathological hypoxia
34. + cells
35. In vivo gene transfer with retroviral vector producer cells for treatment of experimental brain tumors